Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-VII)
BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII
Sponsor: Biotronik, Inc.
A observational or N/A phase clinical study on Acute Coronary Syndrome and Angina Pectoris, this trial is completed. The trial is conducted by Biotronik, Inc. and has accumulated 23 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
23 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 18 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting
-
Apr 2022 — May 2024 [monthly]
Active Not Recruiting
-
May 2021 — Apr 2022 [monthly]
Active Not Recruiting
-
Mar 2021 — May 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting
-
May 2020 — Jun 2020 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .